Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

13P - Hypermethylation of microRNA gene: potential in the diagnosis of lung cancer

Date

15 Oct 2022

Session

Poster display session

Presenters

Irina Pronina

Citation

Annals of Oncology (2022) 33 (suppl_8): S1383-S1430. 10.1016/annonc/annonc1095

Authors

I. Pronina, M. Gubenko, A. Burdennyy, V. Loginov

Author affiliations

  • Institute of General Pathology and Pathophysiology, Moscow/RU
More

Abstract 13P

Background

Non-small cell lung cancer (NSCLC) is one of the most common human cancers. In this regard, the search for new biomarkers for detecting NSCLC at early stages is relevant, and one of these markers may be the methylation of CpG-islands of miRNA genes. The aim of this work was to study the level of methylation of promoter CpG-islands of miRNA genes as promising NSCLC markers.

Methods

A representative set of 80 paired (tumour/normal) NSCLC samples was used in the study. The analysis of methylation was carried out using the method of quantitative methyl-specific PCR. Statistical analysis of methylation levels was performed using a non-parametric Mann-Whitney U-test. The optimal marker systems were selected based on the results of the ROC analysis. Mathematical packages IBM SPSS Statistics 22 are used.

Results

A representative set of 80 paired (tumour/normal) NSCLC samples was used in the study. The analysis of methylation was carried out using the method of quantitative methyl-specific PCR. Statistical analysis of methylation levels was performed using a non-parametric Mann-Whitney U-test. The optimal marker systems were selected based on the results of the ROC analysis. Mathematical packages IBM SPSS Statistics 22 are used. Results. The methylation status of 10 miRNA genes was studied, significant differences were established between methylation levels in tumour samples and histologically normal tissue of NSCLC patients for 8 genes: MIR-124A-1/3, MIR-125B-1, MIR-127, MIR-129-2, MIR-137, MIR-339 and MIR-375 (p‹0.001). Significant correlations were found between the methylation frequency of a number of miRNA genes and NSCLC progression: MIR-125B-1, MIR-137, MIR-124A-3 with cancer stage (p=0.001, 0.004 and 0.001, respectively) and MIR-125B-1 with metastasis (p=0.005). An effective marker system of 4 genes (MIR-125B-1, MIR-137, MIR-129-2, MIR-375) was determined by ROC analysis for the diagnosis of NSCLC at early stages with high clinical sensitivity (90%) and specificity (90 %); AUC value > 0.9.

Conclusions

Thus, new hypermethylated miRNA genes can be used as potential biomarkers for the early diagnosis of NSCLC.

Legal entity responsible for the study

The authors.

Funding

The study was supported by the state assignment of the Ministry of Science and Higher Education of the Russian Federation number FGFU-2022-0007.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.